Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts”

被引：0
|
作者：
Nicolas Simon
Jean Claude Alvarez
机构：
[1] Aix-Marseille University,APHM, INSERM, IRD, SESSTIM, Hop Sainte Marguerite, Service de Pharmacologie Clinique, CAP
[2] Hôpitaux Universitaires Paris-Ile de France-Ouest,TV
[3] APHP,Département de Pharmacologie
[4] Hôpital Raymond Poincaré,Toxicologie
[5] FHU Sepsis,undefined
[6] MasSpecLab,undefined
[7] Plateforme de spectrométrie de masse,undefined
[8] Inserm U-1173,undefined
[9] Université Paris Saclay (Versailles Saint Quentin-en-Yvelines),undefined
来源：
European Journal of Clinical Pharmacology | 2021年 / 77卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：793 / 794
页数：1
相关论文
共 50 条
  • [41] Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients
    Eljaaly, Khalid
    Al-Tawfiq, Jaffar A.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 38
  • [42] The Safety and Efficacy of the Protease Inhibitors Lopinavir/Ritonavir as Monotherapy or Combined with Interferon in COVID-19 Patients
    Kandeel, Mahmoud
    Morsy, Mohamed A. A.
    Abd El-Lateef, Hany M. M.
    Marzok, Mohamed
    El-Beltagi, Hossam S. S.
    Al Khodair, Khalid M. M.
    Albokhadaim, Ibrahim
    Venugopala, Katharigatta N. N.
    PROCESSES, 2023, 11 (02)
  • [43] Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds
    Griffin, Shaun
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 370 : m2650
  • [44] Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trial
    Kaizer, Alexander M.
    Shapiro, Nathan I.
    Wild, Jessica
    Brown, Samuel M.
    Cwik, B. Jessica
    Hart, Kimberly W.
    Jones, Alan E.
    Pulia, Michael S.
    Self, Wesley H.
    Smith, Clay
    Smith, Stephanie A.
    Ng, Patrick C.
    Thompson, B. Taylor
    Rice, Todd W.
    Lindsell, Christopher J.
    Ginde, Adit A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 128 : 223 - 229
  • [45] Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients
    Le, Minh Patrick
    Jaquet, Pierre
    Patrier, Juliette
    Wicky, Paul-Henri
    Le Hingrat, Quentin
    Veyrier, Marc
    Kauv, Juliette
    Sonneville, Romain
    Visseaux, Benoit
    Laouenan, Cedric
    Bouadma, Lila
    Descamps, Diane
    de Montmollin, Etienne
    Peytavin, Gilles
    Timsit, Jean-Francois
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (09) : 2657 - 2660
  • [46] In Reply to the Letter to the Editor Regarding "Aneurysmal Subarachnoid Hemorrhage in COVID-19 Patients: A Case Series"
    Dodd, William S.
    Chalouhi, Nohra
    WORLD NEUROSURGERY, 2021, 154 : 200 - 200
  • [47] Reply to letter to the editor regarding "Use of DPP-4 inhibitors in patients with COVID-19"
    Solerte, Sebastiano Bruno
    D'Addio, Francesca
    Fiorina, Paolo
    ACTA DIABETOLOGICA, 2021, 58 (02) : 247 - 248
  • [48] Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19”
    Sebastiano Bruno Solerte
    Francesca D’Addio
    Paolo Fiorina
    Acta Diabetologica, 2021, 58 : 247 - 248
  • [49] Reply - Letter to the Editor: Vitamin D deficiency in critically ill COVID-19 ARDS patients
    Notz, Quirin
    Stoppe, Christian
    CLINICAL NUTRITION, 2022, 41 (09) : 2038 - 2039
  • [50] Reply to Letter to the Editor: Recommendations for the Care of Pediatric Orthopaedic Patients During the COVID-19 Pandemic
    Schaeffer, Emily K.
    Farrell, Sarah
    Mulpuri, Kishore
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2020, 28 (19) : E851 - E852
12345